Costello syndrome: Difference between revisions

	WikiDoc Resources for Costello syndrome
Articles
Most recent articles on Costello syndrome Most cited articles on Costello syndrome Review articles on Costello syndrome Articles on Costello syndrome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Costello syndrome Images of Costello syndrome Photos of Costello syndrome Podcasts & MP3s on Costello syndrome Videos on Costello syndrome
Evidence Based Medicine
Cochrane Collaboration on Costello syndrome Bandolier on Costello syndrome TRIP on Costello syndrome
Clinical Trials
Ongoing Trials on Costello syndrome at Clinical Trials.gov Trial results on Costello syndrome Clinical Trials on Costello syndrome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Costello syndrome NICE Guidance on Costello syndrome NHS PRODIGY Guidance FDA on Costello syndrome CDC on Costello syndrome
Books
Books on Costello syndrome
News
Costello syndrome in the news Be alerted to news on Costello syndrome News trends on Costello syndrome
Commentary
Blogs on Costello syndrome
Definitions
Definitions of Costello syndrome
Patient Resources / Community
Patient resources on Costello syndrome Discussion groups on Costello syndrome Patient Handouts on Costello syndrome Directions to Hospitals Treating Costello syndrome Risk calculators and risk factors for Costello syndrome
Healthcare Provider Resources
Symptoms of Costello syndrome Causes & Risk Factors for Costello syndrome Diagnostic studies for Costello syndrome Treatment of Costello syndrome
Continuing Medical Education (CME)
CME Programs on Costello syndrome
International
Costello syndrome en Espanol Costello syndrome en Francais
Business
Costello syndrome in the Marketplace Patents on Costello syndrome
Experimental / Informatics
List of terms related to Costello syndrome

	Costello syndrome;
OMIM	218040
DiseasesDB	32846

Revision as of 19:30, 8 June 2010

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

For patient information click here

Costello syndrome is a genetic disorder that affects many parts of the body. This condition is characterized by delayed development and mental retardation, distinctive facial features, loose folds of extra skin (especially on the hands and feet), and unusually flexible joints. Heart abnormalities are common, including a very fast heartbeat (tachycardia), structural heart defects, and overgrowth of the heart muscle (hypertrophic cardiomyopathy). Infants with Costello syndrome may be large at birth, but have difficulty feeding and grow more slowly than other children. Later in life, people with this condition have relatively short stature and many lack growth hormone.

Beginning in early childhood, people with Costello syndrome have an increased risk of developing certain cancerous and noncancerous tumors. Small growths called papillomas are the most common noncancerous tumors seen with this condition. They usually develop around the nose and mouth or near the anus. The most frequent cancerous tumor associated with Costello syndrome is a soft tissue tumor called a rhabdomyosarcoma. Other cancers also have been reported in children and adolescents with this disorder, including a tumor that arises in developing nerve cells (neuroblastoma) and a form of bladder cancer (transitional cell carcinoma).

Genetics

Mutations in the HRAS gene cause Costello syndrome. The HRAS gene provides instructions for making a protein that helps control cell growth and division. Mutations that cause Costello syndrome lead to the production of an HRAS protein that is permanently active. Instead of triggering cell growth in response to particular signals from outside the cell, the overactive protein directs cells to grow and divide constantly. This unchecked cell division may predispose to the development of benign and malignant tumors. It remains unclear how mutations in the HRAS gene cause the other features of Costello syndrome, but many of the signs and symptoms may result from cell overgrowth and abnormal cell division.

Costello syndrome is inherited in an autosomal dominant manner, which means one copy of the altered gene is sufficient to cause the disorder. Almost all cases have resulted from new mutations, and occur in people with no history of the disorder in their family. This condition is rare; 200 to 300 (20/04/2007)cases have been reported worldwide.

A support group for families affected by Costello syndrome was founded in the UK in 1997. Although based in the UK, the support group runs a web site, and Listserve for families, and has formed a strong international community. The UK support group is a registered charity. In 2001 a similar not-for-profit organization for Costello syndrome was founded in the USA. The two organizations work hand in hand, providing a high level of support and information with the aim of gaining a much better understanding of this rare disorder.

The support group has a membership of 160 families world wide (05/03/2007)